Empresa extranjera obtiene aprobación CE Mark para comercializar un novedoso dispositivo médico gracias a su estudio clínico-científico en Colombia

Mitralign, Inc., un fabricante de soluciones innovadoras para la reparación de la valvula mitral y tricúspide por medio de catéter, ha anunciado que su Sistema de Anuloplastia Percutánea Mitralign (MPAS, por sus siglas en inglés) ha recibido la aprobación CE Mark para su uso en el tratamiento de regurgitación mitral funcional. Esta aprobación ofrece una novedosa alternativa de tratamiento para pacientes con síntomas de regurgitación mitral funcional. La aprobación le permitirá a Mitralign comercializar su sistema MPAS en la Unión Europea. El estudio clínico en humanos para validar la seguridad y eficacia del MPAS fue conducido a través de Interventional Concepts en el centro de investigación cardiovascular de una clínica líder en Cali, Valle.

Julio G. Martinez-ClarkFebruary 23, 2016Comment

Annual ranking reveals that Colombia has the best hospitals and clinics in Latin America

Talent, innovation and service explain why Colombia leads the annual ranking of the best clinics and hospitals in Latin America. According to America Economía magazine's annual ranking of clinics and hospitals in Latin America, Colombia leads the region with 22 of the best institutions out of 43 in the list. Medellin's General Hospital leads the ranking as the best public health institution in Latin America.

University of Miami Physicians Test New Percutaneous Valve in Colombia

The Miller School’s International Medicine Institute and Angiografía de Occidente S.A., the institute’s affiliate in Cali, Colombia, are collaborating on assessing the feasibility and safety of Direct Flow, Inc.’s new transcatheter aortic valve implantation device. Interventional Concepts, Inc. provided regulatory and logistics support services for this trial.

Julio G. Martinez-ClarkJuly 28, 2015Comment

Colombia promotes itself as a destination for clinical research

Marca País, Procolombia's division in charge of managing Colombia's country brand abroad, has signed an alliance with Interventional Concepts, a leading clinical development firm in Miami, FL USA with an office in Colombia and focused on conducting clinical trials in Colombia (www.interventionalconcepts.net), to work together to position Colombia as the premier destination in Latin America to conduct clinical trials. Colombia is able to provide the biopharma and medical device industries with a high enrollment rate, regulatory efficiency by the Instituto Nacional de Vigilancia de Medicamentos (INVIMA), competitive costs, highly qualified and motivated bilingual investigators and boasting an ideal geographical location with fast and direct airline connectivity from the major centers of innovation in the U.S. and Europe

Julio G. Martinez-ClarkMay 28, 2015colombia, clinical trial, clinical researchComment

CenterWatch, the leading publication for clinical trials, has written about our work in Colombia

"Miami-based consultancy bringing more U.S. startups' phase I trials to Colombia" -CenterWatch Weekly, April 6, 2015. This was the title of a recent front-page article that CenterWatch, the leading clinical research publication, has published profiling our work in Colombia.

Colombia, Clinical TrialsJulio G. Martinez-ClarkApril 6, 2015centerwatchComment

IMH Assets Corp., dba bioaccess™ | 1200 Brickell Avenue, Suite 1950 #1034, Miami, FL 33131 | 166 Geary St. 15th FL #1181, San Francisco, CA 94108

CALL or TEXT US: +1 (407) 205-8930‬ | EMAIL US | BOOK A MEETING